Chen Bihua

Chen Bihua is listed in filings as otherFormer, 10% Owner at MoonLake Immunotherapeutics. This profile follows SEC Form 4 activity through Oct 1, 2025, including sale activity. Recent filings connect the profile to MoonLake Immunotherapeutics (MLTX), Biomea Fusion, Inc. (BMEA), and BridgeBio Oncology Therapeutics Inc. (BBOT). The current snapshot covers public activity from Jun 13, 2024 to Oct 1, 2025. Reported amounts are shown as $40.6K to $25.7M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.